Italy
Research Article
Acute Kidney Injury Hyperkalemia in Patients Undergoing Renin-Angiotensin-Aldosterone Blockade
Author(s): Francesco Falaschi, Lorena Fenoglio, Mirosa Dellagiovanna, Valentina de Vecchi, Vincenzo Sepe and Maria Antonietta BressanFrancesco Falaschi, Lorena Fenoglio, Mirosa Dellagiovanna, Valentina de Vecchi, Vincenzo Sepe and Maria Antonietta Bressan
Introduction: In order to minimize the risk of hyperkalemia (hK+) in patients with heart failure (HF), in 2005 and 2009 ACC/AHA (American College of Cardiology; American Heart Association) joint guidelines recommended associating renin-angiotensin system (RAS) inhibition with low-dose ALD-block in patients with serum creatinine (sCr) less than 2.5 mg/dl and serum potassium (sK+) lower than 5 mEq/l. A prevalence of HF in individuals aged 65 and over with mild renal failure at risk of hyperkalemia is steeply increasing. Such data has persuaded us to analyze the association between over-65 HF standard treatment and hK+.
Aim: This observational retrospective study analyzed emergency room admissions aged 65 and over undergoing ACEI with ALD-block or potassium sparing diuretics (K+-sparing) and hK+ (sK+ > 6 mEq/l) over a one year period, from Jan.. Read More»
DOI:
10.4172/2161-0959.1000201
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report